During the past decade, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins conducted 533 clinical trials. In the 10-year time frame, 533 clinical trials started and 439 clinical trials were completed, i.e. on average, 82.4% percent of trials that started reached the finish line to date. In the past 5 years, 179 clinical trials started and 233 clinical trials were completed. i.e. 130.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" #1 sponsor was "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 341 trials, followed by "National Cancer Institute (NCI)" with 287 trials sponsored, "Children's Oncology Group" with 128 trials sponsored, "Radiation Therapy Oncology Group" with 49 trials sponsored and "Eastern Cooperative Oncology Group" with 49 trials sponsored. Other sponsors include 499 different institutions and companies that sponsored additional 197 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" #1 collaborator was "National Cancer Institute (NCI)" with 571 trials as a collaborator, "Bristol-Myers Squibb" with 37 trials as a collaborator, "NRG Oncology" with 37 trials as a collaborator, "Merck Sharp & Dohme LLC" with 20 trials as a collaborator and "SWOG Cancer Research Network" with 17 trials as a collaborator. Other collaborators include 476 different institutions and companies that were collaborators in the rest 243 trials.

According to Clinical.Site data, the most researched conditions in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" are "Leukemia" (84 trials), "Lymphoma" (73 trials), "Prostate Cancer" (62 trials), "Breast Cancer" (61 trials) and "Pancreatic Cancer" (48 trials). Many other conditions were trialed in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" in a lesser frequency.

Most popular intervention types in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" are "Drug" (1095 trials), "Other" (369 trials), "Biological" (362 trials), "Procedure" (273 trials) and "Radiation" (228 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (198 trials), "Cyclophosphamide" (94 trials), "radiation therapy" (86 trials), "Nivolumab" (73 trials) and "Pharmacological Study" (70 trials). Other intervention names were less common.

The vast majority of trials in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" are 1112 trials for "All" genders, 145 trials for "Female" genders and 96 trials for "Male" genders.

Currently, there are NaN active trials in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins". 6 are not yet recruiting, 183 are recruiting, 266 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 702 completed trials in Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 9 suspended trials, and 147 terminated clinical trials to date.

Out of the total trials that were conducted in Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 352 "Phase 1" clinical trials were conducted, 682 "Phase 2" clinical trials and 278 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 83 trials that are defined as “Not Applicable".